The fact that such diseases are known risk factors for severe COVID-19, along with the pro-inflammatory effect that CHIP may have on myeloid cells [2, 3], has given rise to the hypothesis that CHIP-exacerbated inflammatory signaling may be associated with the severity of SARS-CoV-2 infection [5]. This evidence concerns the gene STUB1 and COVID-19.